Normalized circulating Tfh and Th17 associates with improvement in myasthenia gravis treated with ofatumumab
ObjectiveTo assess the effect of B cell depletion therapy (BCDT) on circulating T follicular helper (cTfh) and circulating T helper 17 (cTh17) cells and its relation to clinical improvement in patients with myasthenia gravis (MG).Methods28 anti-AchR positive MG patients treated with ofatumumab and 2...
Main Authors: | Xiaodong Song, Yang He, Yang Huo, Hong Jiang, Yao Yu, Yue Sun, Zunjing Liu, Zhaoxu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1280029/full |
Similar Items
-
Therapeutic effect of ofatumumab in patients with myasthenia gravis: immunoregulation of follicular T helper cells and T helper type 17 cells
by: Shasha Li, et al.
Published: (2023-12-01) -
Novel Immunotherapies for Myasthenia Gravis
by: Nair SS, et al.
Published: (2023-04-01) -
Rituximab treatment in myasthenia gravis
by: Ana Vesperinas-Castro, et al.
Published: (2023-10-01) -
AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2‐STAT3 signaling pathway
by: Ying Zhang, et al.
Published: (2023-06-01) -
Triptolide regulates the balance of Tfr/Tfh in lupus mice
by: Xia Zhao, et al.
Published: (2023-07-01)